Creative Biolabs launches its unique TAC-T cell therapy platform as an alternative option for malignancy research. We have been committed to researching TAC-T cell therapy since 2018 and are constantly seeking new platforms to expand into new areas. Therefore, a seamless of TAC-specific virus particle products has been developed and broadly analyzed in many cancer states.
Recently, we have offered custom TAC services to help overcome the technical challenges of multiple TAC-T cell therapy projects. This includes the design and construction of various TAC-specific virus particles by verifying different varieties of functional TAC elements. From TAC viral vector construction, and production to titer testing, our experienced team will provide efficient technical support to assist in the further development of TAC therapy.
Fig. 1 Example of TAC Virus Titer Test Results.
Through our comprehensive early discovery, nonclinical, and commercialization services, Creative Biolabs is committed to developing the most promising TAC-specific virus particles for our clients. With in-depth expertise in vector design, vector construction, as well as cell-based assay studies, we can also provide well-mature TAC-specific virus particle manufacturing services. If you are interested in our services, please contact us for more details. Please see the main TAC virus particle product details below.
